HomeTrialNCT07143669
🔬NCT07143669RECRUITING

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Study Summary

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment450 participants
Primary Completion
Lead SponsorBlueprint Medicines Corporation
Data Retrieved2026-04-11 04:08:23.597258+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.